Takagi et al. demonstrated that the mTOR protein was significantly phosphorylated after nesfatin-1 treatment of the endometrial carcinoma cell line, which resulted in enhanced cell proliferation and migration properties [50]. The gene discussed is MTOR; the disease is endometrial carcinoma.